France · Question · Question écrite
12383
Question 12383 — women
Introduced
—
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
—
Summary
Mr. Hervé Pellois draws the attention of the Minister of Solidarity and Health to the situation of women victims of the Essure definitive sterilization device produced by the Bayer laboratory. As has been observed, Essure implants (4 cm metal implants inserted into the fallopian tubes), aimed at obstructing these tubes in order to prevent any fertilization, locally create inflammatory reactions of the fibrosis type. Indeed, these implants are composed of allergenic heavy metals (nickel, titanium, chromium, iron, tin, platinum, iridium), and PET fibers (polyethylene terephthalate), endocrine disruptors in certain conditions. This contraceptive method, presented as non-invasive, compared to traditional tubal ligation, causes numerous undesirable effects in thousands of French women: extreme fatigue preventing them from carrying out daily activities or carrying out professional activity, muscle or joint pain, neurological disorders, abdominal pain, painful premenstrual syndrome, headaches, dizziness, shortness of breath or even heart rhythm disturbances. If the pharmaceutical laboratory Bayer HealthCare announced on Monday September 18, 2017 that it was ending the marketing of Essure definitive contraceptive implants in France, However, he has not planned a protocol for removing these implants and the women who wear them must undergo major surgery to extract them (removal of the tubes, coupled or not with removal of the uterus). This is the reason why many women with Essure implants have joined together within the association Mutual Aid, Support and Information Network on Tubular Sterilization (RESIST), approved by the Ministry of Health. The requests from this association relate to the following points: the establishment of appropriate surveillance monitoring for women who do not present symptoms, the establishment of appropriate monitoring monitoring for explanted women and above all that an information note be sent to all health professionals and that the ministry inform women carrying Essure of the risks they face. incur. He would therefore like to know whether the Government intends to respond favorably to these requests.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/15/questions/QANR5L15QE12383
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L15QE12383